This study was conducted to determine the effects of chestnut hydrolysable tannin (CHT) on intake, digestibility, rumen fermentation, milk yield and somatic cell count in crossbred dairy cows (>75% Holstein Friesian). Four crossbred dairy cows (467.6 ± 35.2 kg BW) were assigned to be supplemented with one of four levels of CHT according to a 4 × 4 Latin square design. Dietary treatments included the control (without CHT supplementation) and CHT treatments that consisted of supplementation with 3.15, 6.30 and 9.45 g CHT/day. Rice straw was given ad libitum. The results showed that increasing levels of CHT tended to quadratically decrease rice straw intake (p = 0.06). However, total dry matter intake (DMI) and other nutrients were not different (p > 0.05) among the dietary treatments. The apparent digestibility of DM, organic matter (OM) and crude protein (CP) in cows with CHT treatments were higher (p < 0.05) than those of control cows. Milk yield and milk composition were not different (p > 0.05) among treatments. Lactose yield tended to increase linearly (p = 0.09) as CHT supplementation increased. Ruminal pH and ammonia nitrogen (NH₃-N) were not different (p > 0.05), but total volatile fatty acids (VFAs) increased linearly (p < 0.05) as CHT levels increased. The somatic cell count (SCC) and somatic cell score (SCS) in the CHT treatments were different (p < 0.01) than those in the control treatment. In conclusion, it appears that CHT supplementation improved feed utilization and influenced SCC in crossbred dairy cows. Long-term research is needed to confirm the benefit of CHT supplementation.

Background and Aim: Hydrolyzable tannins are an important group of secondary plant metabolites, which are known for antimicrobial activity. This study aimed to assess the efficiency with which a hydrolyzable tannin extract from sweet chestnut wood (Castanea sativa Mill.) could inhibit mastitis-causing bacteria in vitro. Materials and Methods: The negative control used was sterile water, and the positive controls were penicillin and gentamicin. The treatments included five concentrations of hydrolyzable tannins (63, 190, 313, 630, and 940 mg/mL). In cows with subclinical mastitis, the bacteria causing the disease were isolated and identified. Then, the antibacterial activity of the hydrolyzable tannin extract was assessed by the disk diffusion method, by determining the minimum inhibitory concentration (MIC) and by determining the minimum bactericidal concentration (MBC). Results: Penicillin inhibited (p0.05) the growth of Streptococcus agalactiae, Escherichia coli, and Klebsiella pneumoniae. However, gentamicin and hydrolyzable tannins could inhibit (p<0.01) all isolated bacteria. Increasing the concentration of hydrolyzable tannin extract resulted in a quadratic increase in the inhibition zone diameter of S. aureus and S. agalactiae and a linear increase in the inhibition zone diameter of E. coli, K. pneumoniae, and P. aeruginosa. In addition, 630 and 940 mg/mL of hydrolyzable tannin extract showed the highest antibacterial activity against S. agalactiae and E. coli (p<0.01), while 940 mg/mL concentration had the highest antibacterial activity against K. pneumoniae (p<0.01). The MIC and MBC of the extract were 27.3-190 mg/mL and 58.8-235 mg/mL, respectively, with the MBC: MIC ratio being 2:1. Conclusion: The antimicrobial activity of the hydrolyzable tannin extract against subclinical mastitis bacteria was comparable to the antibiotics (positive controls) at concentrations over 630 mg/mL. Although these in vitro findings are promising, further research is needed to determine whether hydrolyzable tannins could be used to control or prevent subclinical mastitis in dairy cows.